Terminal · Institutions
Every 13F-reported equity position this quarter, with its quarter-over-quarter change — each row traces back to the SEC filing.
Every 13F-reported equity position this quarter, with its quarter-over-quarter change — each row traces back to the SEC filing.
GENERAL ATLANTIC, L.P. (CIK 1017645) reported $2.15B across 12 reported positions in its SEC 13F filing for 2026-03-31. Largest positions: DLO ($605.1M, 28.17%), CHYM ($398.2M, 18.53%), XP ($391.6M, 18.23%), ALKT ($240.3M, 11.19%), PHVS ($226.9M, 10.56%). Source: SEC Form 13F.
| Rank | Ticker | Company | Value | % Portfolio | Shares | Action |
|---|---|---|---|---|---|---|
| 1 | DLO | DLOCAL | $605.1M | 28.17% | 46.7M | Hold |
| 2 | CHYM | CHIME | $398.2M | 18.53% | 21.3M | Hold |
| 3 | XP | XP, INC | $391.6M | 18.23% | 20.6M | Trimmed |
| 4 | ALKT | ALKAMI | $240.3M | 11.19% | 15.3M | Added |
| 5 | PHVS | PHARVARIS | $226.9M | 10.56% | 8.0M | Hold |
| 6 | EWCZ | EUROPEAN WAX CENTER | $75.8M | 3.53% | 13.1M | Hold |
| 7 | RVMD | REVOLUTION MEDICINES | $68.8M | 3.20% | 707,791 | Trimmed |
| 8 | NRIX | NURIX THERAPEUTICS | $63.6M | 2.96% | 4.1M | Trimmed |
| 9 | CNTA | CENTESSA PHARMACEUTICALS | $53.8M | 2.50% | 1.4M | Trimmed |
| 10 | RSKD | RISKIFIED | $20.9M | 0.97% | 5.3M | Hold |
| 11 | GROV | GROVE COLLABORATIVE | $3.2M | 0.15% | 2.5M | Hold |
| 12 | BULL | WEBULL | $243,917 | 0.01% | 50,816 | Hold |
| 13 | ALHC | ALIGNMENT HEALTHCARE | $0 | 0.00% | 0 | Exited |
Source: SEC Form 13F filings · as of 2026-03-31